Treatment of Acute Gout with AKI Secondary to NSAIDs
Introduction to Treatment
- The American College of Rheumatology recommends using corticosteroids as first-line therapy for acute gout in patients with AKI secondary to NSAIDs, specifically oral prednisone 30-35 mg daily for 3-5 days, or intra-articular corticosteroid injection if only one or two joints are involved 1, 2
Treatment Options
- Corticosteroids are considered first-line therapy in patients without contraindications due to their safety profile and low cost, with prednisolone 35 mg daily for 5 days being effective for acute gout 2
- Intra-articular aspiration and injection of long-acting steroid is an effective and safe treatment for an acute attack, particularly when one or two large joints are involved 3
- If 1-2 joints are involved, perform arthrocentesis and intra-articular corticosteroid injection, such as triamcinolone acetonide 40 mg for large joints like the knee 1, 3
- If polyarticular involvement occurs, use oral corticosteroids: prednisone 30-35 mg daily for 3-5 days 1, 2
Critical Monitoring Points
- Monitor renal function closely during treatment since the patient has demonstrated susceptibility to drug-induced AKI 4
- Avoid combining corticosteroids with NSAIDs due to concerns about synergistic gastrointestinal toxicity 4
- Check for contraindications to corticosteroids, such as uncontrolled diabetes, active infection, or recent GI bleeding, before prescribing 1
Long-Term Management Considerations
- Do not interrupt ongoing urate-lowering therapy during the acute attack 1, 2
- Once the acute attack resolves, ensure the patient is on appropriate urate-lowering therapy, such as allopurinol or febuxostat, to prevent future attacks 2, 3
- When starting or adjusting urate-lowering therapy, provide prophylaxis with low-dose colchicine or low-dose NSAIDs for at least 8 weeks, but in patients with AKI history, use colchicine only after renal function normalizes and with appropriate dose adjustment 1, 2